Walgreens Could Continue to Weaken

The company reported earnings and the shares have rolled over and turned down.

NovoCure Gaps Sharply Higher for a Breakout: How to Play It

Let's check out the charts and indicators of both NovoCure and Zai Lab.

Rain Oncology Could See Sunny Days Ahead

The oncology company's stock has been correcting sideways for a few months but seems poised for renewed gains.

Humana Is Poised for Further Declines

Let's set a new strategy for the first quarter.

Centene's Long Side Continues to Look Risky

Let's check in on this healthcare company.

GE Is Not a Lost Cause as Healthcare Spinoff Gets Set to Join S&P 500

GE will ultimately break into three separate, independent, publicly traded companies. Next week Healthcare will be the first to be spun off.

Guardant Health Looks Downright Sickly

The charts of the oncology company are nothing but bearish and its stock could be in for more downside action ahead.

Run on Vaccine Bookings, Medicines in Hong Kong as China Eases Travel Rules

We expect Chinese travelers to return in large numbers, as Asian nations slap new restrictions on arrivals from the last major nation to learn to "live with Covid."

ETF Issuer Subversive Grabs My Attention With New SANE Fund and 2 Others

The diverse funds focus on decarbonization efforts, food security and mental health.

Replimune Breaks Out: Could Rise 30% From Here

Let's check out the charts and indicators of this biotech name.